Summary:
The primary objective of this study is to compare the overall response (clinical and microbiologic combined response) of oral sulopenem etzadroxil/probenacid vs. oral ciprofloxacin for the treatment of uncomplicated urinary tract infection in adult women at the primary time-point.
Qualified Participants Must:
• Be at least 18 years of age
•
Have had current UTI symptoms for at least 24 hours but no more than 4 days
•
Able to swallow large pills whole
Qualified Participants May Receive:
- Compensation for time and travel expenses
- Study medication or Ciproflaxin for treatment of UTI
- Study related procedure such as blood work, ECG, physicals with a board certified physician